Parnell Pharma Balance Sheet - Annual (OTCMKTS:PARNF)

Add to My Stocks
$0.2 $0.05 (20%) PARNF stock closing price Jun 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Parnell Pharma balance sheet. Financial strength can be guaged by performing Parnell Pharma stock analysis and by analyzing the balance sheet. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. The Parnell Pharma balance sheet for 2016 shows total assets of $35.38M. The company has a asset turnover ratio of . Also see: Parnell Pharma revenue and Parnell Pharma operating cash flow for the same year.

View latest 10 year balance sheet data to check Parnell Pharma financial performance.
show more
Fiscal year is Jan - Dec201620152014
Marketable Securities---
Raw Materials---
Work In Progress---
Finished Goods1.86M1.67M-
Notes Receivable---
Other Current Assets---
Total Current Assets
Property Plant & Equipment13.35M13.1M-
Accumulated Depreciation4.33M3.56M-
Net Property Plant & Equipment
Investment & Advances---
Other Non-Current Assets---
Deferred Charges---
Deposits & Other Assets---
Total Assets
Notes Payable--3.92M
Accounts Payable5.85M5.1M7.37M
Current Portion Long-Term Debt-2.35M-
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities---
Total Current Liabilities
Deferred Taxes/Income---
Convertible Debt---
Long-Term Debt22.18M10.8M-
Non-Current Capital Leases---
Other Long-Term Liabilities---
Total Liabilities
Minority Interest---
Preferred Stock---
Common Stock Net47.24M41.65M47.36M
Capital Surplus---
Retained Earnings-41.1M-25.27M-16.98M
Treasury Stock---
Other Liabilities-0.13M-1.13M-1.35M
Shareholders Equity5.99M15.24M29.02M
Total Liabilities & Shareholders Equity35.38M34.78M41.28M
All figures in USD. M: Millions of USD, B: Billions of USD.

Apart from balance sheet items, an investor would do well to keep track of the Parnell Pharma stock price by looking at Parnell Pharma historical stock prices. One can compare PE with industry average by looking at the Parnell Pharma PE ratio chart. The common balance sheet items are:

  • Assets: PARNF total assets, which was at $35.38M for 2016 is a balance sheet item representing value of what Parnell Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. PARNF stock had total liabilities of $29.38M for the year 2016.

Parnell Pharma Balance Sheet - Key Ratios